What accounts for lower accuracy of myPath found by some studies

No test is 100% accurate. But accuracy of the myPath result has been compared to clinical outcomes in more than 300 cases, and false-negatives occurred in less than 5 – 10% of all melanomas. . The epidemiologic evidence indicates that the majority of “challenging to diagnose” neoplasms are benign, not malignant.